Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 41:2197-2204, doi:10.1016/S0735-1097(03)00464-9
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kumagai, K.
Right arrow Articles by Saku, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kumagai, K.
Right arrow Articles by Saku, K.

Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation

Koichiro Kumagai, MD*,*, Hideko Nakashima, MD*, Hidenori Urata, MD*, Naoki Gondo, MD*, Kikuo Arakawa, MD, FACC* and Keijiro Saku, MD, FACC*

* Department of Cardiology, School of Medicine, Fukuoka University, Fukuoka, Japan



View larger version (18K):

[in a new window]
 
Figure 1 Time course of the percent changes in the atrial effective refractory period (AERP) of the right atrial appendage and intra-atrial conduction time (CT) from the right atrial appendage to the lower right atrial wall at a basic cycle length of 300 ms, and the mean duration of induced atrial fibrillation (AF) in the control (white circles, white bars) and candesartan (black circles, black bars) groups. The degree of AERP shortening was similar between the two groups, the intra-atrial CT in the candesartan group was significantly shorter than that in the control group, and the mean AF duration in the candesartan group was significantly shorter than that in the control group. §p < 0.01, *p < 0.05 compared with the control group.

 


View larger version (74K):

[in a new window]
 
Figure 2 Representative histologic sections of the right atrial free wall from each group (Masson trichrome stain) from a sham dog (A), a fifth week rapid pacing dog (B), and a fifth week rapid pacing with candesartan treated dog (C). In the sham dog, the intracellular space appeared normal. In the control dog, extensive interstitial fibrosis, evidenced by Masson trichrome stain, was found. In the candesartan treated dog, interstitial fibrosis was attenuated. Magnification: x400.

 


View larger version (23K):

[in a new window]
 
Figure 3 The percentage of fibrosis of the free walls and appendages in both atria after five weeks of pacing. The percentage of fibrosis in all atrial regions in the candesartan group was markedly lower than that in the control, although greater than that in the sham group. Hatched bars = sham group; white bars = control group; black bars = candesartan group. {dagger}p < 0.001 compared with the control group. *p < 0.05 compared with the sham group. RAA = right atrial appendage; RAFW = right atrial free wall; LAA = left atrial appendage; LAFW = left atrial free wall.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement